Episode 92 - Luc Dochez - Managing Partner at Droia Ventures

Today we’re joined by one of Europe’s most respected builders of biotechnology companies — Luc Dochez.
Luc is a scientist-turned-entrepreneur whose career has helped shape the next generation of therapies in oncology, rare diseases, and genetic medicine. Over the past two decades, he has co-founded and led multiple biotech companies, including Vico Therapeutics, Montis Biosciences, and Pharvaris, and he served as CEO of Tusk Therapeutics, guiding it all the way to its acquisition by Roche.

Before becoming a serial entrepreneur, Luc held senior leadership roles at Prosensa, TiGenix, and other pioneering biopharma firms, building a reputation for turning cutting-edge science into real therapeutic opportunities. Today, as a Managing Partner at DROIA Ventures, he invests in and mentors the startups pushing the boundaries of precision medicine.

With a background that spans pharmacy, business strategy, company formation, and venture capital, Luc brings a uniquely holistic perspective on how breakthrough therapies go from idea to impact.